Abstract: The present invention provides the use of L-2-oxothiazolidine-4-carboxylic acid for the treatment of type 2 diabetes(NIDDM; non-insulin dependent diabetes mellitus). The present invention also provides the pharmaceutical composition containing the chemical L-2-oxothiazolidine-4-carboxylic acid as an active agent for the treatment of type 2 diabetes and the method for the treatment of type 2 diabetes comprising administering to a mammal having the same disease.
Type:
Application
Filed:
June 6, 2001
Publication date:
September 26, 2002
Applicant:
Advanced Biochemicals Inc.
Inventors:
Uh-Hyun Kim, Myung-Kwan Han, Young-Mi Shin, Kwang-Hyun Park, Kum-Jae Park